Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2017 04/18/2017 04/19/2017 04/20/2017 04/21/2017 Date
174.42(c) 175.29(c) 178.03(c) 177.16(c) 175.29(c) Last
586 452 676 446 1 144 825 1 085 103 1 303 066 Volume
+0.43% +0.50% +1.56% -0.49% -1.06% Change
More quotes
Financials ($)
Sales 2017 2 650 M
EBIT 2017 713 M
Net income 2017 485 M
Finance 2017 832 M
Yield 2017 -
Sales 2018 3 008 M
EBIT 2018 855 M
Net income 2018 581 M
Finance 2018 1 276 M
Yield 2018 -
P/E ratio 2017 53,36
P/E ratio 2018 44,50
EV / Sales2017 9,37x
EV / Sales2018 8,10x
Capitalization 25 645 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
04/20 ILLUMINA : The Human Vaccines Project, Vanderbilt And Illumina Join Forces To De..
04/20 ILLUMINA : Launches the VeriSeq™ NIPT Solution in Europe
04/18 ILLUMINA : Technical Reports on Biotech Stocks -- CytRx, Achaogen, Jaguar Animal..
04/14 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – Director Sold 3,000 shares ..
04/12 ILLUMINA : Federal Contracts Awarded by Federal Agencies in Washington (April 12..
04/12 ILLUMINA : MILITARY $95,931 Federal Contract Awarded to Illumina
04/12 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – Director Sold 600 shares of..
04/11 ILLUMINA : Debuts Noninvasive Prenatal Testing Software
04/11 ILLUMINA : to Announce First Quarter 2017 Financial Results on Tuesday, April 25..
04/10 ILLUMINA : Combine Solicitation - Illumina Consumables and Reagents
More news
Sector news : Advanced Medical Equipment & Technology - NEC
04/10DJCorrections & Amplifications -- WSJ
03/28DJPHILIPS : to Buy Australian pharmacy Sleep Services Firm
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA, INC. 
2015We anticipate a reversal
2013End of the technical recovery
More Strategies
Latest Tweets
06:21aIllumina upgraded by Vetr Inc. to strong-buy. $196.75 PT.  
05:09aIllumina $ILMN Receives Daily Media Impact Score of 0.20  
04/233 Things to Look for in Illumina's Q1 Results: Motley Fool  
04/22Capstone Asset Management Co. Sells 273 Shares of Illumina, Inc. $ILMN  
04/21RECAP 4/21 +Chatter: $PANW -Chatter: $ILMN
1
More tweets
Qtime:54
News from SeekingAlpha
04/09 WEEK IN REVIEW : Zai Lab Partners With GE On China Biologics Manufacturing
03/29 Cowen bullish on growth of next-gen sequencing, says Pac Bio's systems best f..
03/16 Trump's proposed 2018 budget trims NIH funding 20%; healthcare stocks in the ..
03/02 Grail Approaches Unicorn Status
03/01 GRAIL repurchases part of Illumina's stake, now at 20%
Advertisement
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 164 $
Spread / Average Target -6,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Norman Fjeldheim Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.36.90%25 645
THERMO FISHER SCIENTIF..9.88%60 654
DANAHER CORPORATION4.96%56 710
BOSTON SCIENTIFIC CORP..14.93%34 033
PHILIPS5.16%30 404
INTUITIVE SURGICAL, IN..28.27%29 967
More Results